(Q44436105)

English

No Influence of Obesity on the Pharmacokinetics and Pharmacodynamics of Melagatran, the Active Form of the Oral Direct Thrombin Inhibitor Ximelagatran

scientific article published on January 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

No influence of obesity on the pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

No Influence of Obesity on the Pharmacokinetics and Pharmacodynamics of Melagatran, the Active Form of the Oral Direct Thrombin Inhibitor Ximelagatran (English)

1 reference

10.2165/00003088-200342050-00006

https://api.crossref.org/works/10.2165/00003088-200342050-00006

1 January 2024

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

1 reference

10.2165/00003088-200342050-00006

https://api.crossref.org/works/10.2165/00003088-200342050-00006

1 January 2024

pharmacodynamics

1 reference

based on heuristic

inferred from title

1

object named as

Troy C. Sarich

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12739986

1 January 2024

author name string

Renli Teng

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Maria Wollbratt

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Robert Homolka

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Mia Svensson

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Gary R. Peters

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12739986

1 January 2024

Ulf G. Eriksson

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12739986

1 January 2024

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Clinical Pharmacokinetics

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

485-492

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

https://scigraph.springernature.com/pub.10.2165/00003088-200342050-00006

0 references

Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12739986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time trends in obesity: an epidemiological perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/12739986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/12739986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of melagatran, a new low-molecular-weight thrombin inhibitor, on thrombin and fibrinolytic enzymes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12739986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12739986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12739986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12739986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of melagatran and the effect on ex vivo coagulation time in orthopaedic surgery patients receiving subcutaneous melagatran and oral ximelagatran: a population model analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12739986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absorption, distribution, metabolism, and excretion of ximelagatran, an oral direct thrombin inhibitor, in rats, dogs, and humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/12739986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of melagatran, a novel, direct thrombin inhibitor, in human plasma and urine by liquid chromatography-mass spectrometry.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12739986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of creatinine clearance from serum creatinine

1 reference

https://pubmed.ncbi.nlm.nih.gov/12739986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/12739986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thrombin and antithrombotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/12739986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of obesity on pharmacokinetics implications for drug therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12739986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: intestinal absorption properties, biochemical and pharmacodynamic effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/12739986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective study of the incidence of deep-vein thrombosis within a defined urban population

1 reference

https://pubmed.ncbi.nlm.nih.gov/12739986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12739986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12739986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12739986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Journal of Chromatography B: Biomedical Sciences and Applications

16

766

47

author name string

Larsson

publication date

2002

1 reference

10.2165/00003088-200342050-00006

https://api.crossref.org/works/10.2165/00003088-200342050-00006

1 January 2024

Identifiers

10.2165/00003088-200342050-00006

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44436105&oldid=2144105886"